EXAM 2026 STUDY GUIDE | 200 VERIFIED
PRACTICE QUESTIONS & ANSWERS | ATI
PHARMACOLOGY EXAM PREP
ATI CMS PHARMACOLOGY PROCTORED EXAM 2026 STUDY GUIDE
200 VERIFIED PRACTICE QUESTIONS & ANSWERS
DOCUMENT OVERVIEW
• This comprehensive study guide contains 200 verified practice questions covering
all major pharmacology topics tested on the ATI CMS Pharmacology Proctored
Exam, designed to build mastery through repetition and clinical application.
• Study this material by reviewing questions systematically, understanding EXPERT
RATIONALE deeply, and using incorrect answers as learning opportunities to
strengthen weak areas before the proctored exam.
QUESTIONS 1-30: PHARMACOKINETICS, PHARMACODYNAMICS & DRUG
ADMINISTRATION
1) A nurse is preparing to administer a medication via IV push. Which of the
following describes the most direct route for drug administration?
A) Transdermal patch application
B) Intramuscular injection into the deltoid muscle
C) Intravenous push into a peripheral vein
D) Sublingual tablet placement under the tongue
E) Oral tablet swallowed with water
Correct Answer: C) Intravenous push into a peripheral vein
,EXPERT RATIONALE: Intravenous push administration delivers medication directly
into the bloodstream, providing the most direct route and fastest onset of action.
The IV route bypasses absorption and first-pass metabolism, allowing for
immediate therapeutic effect. Transdermal, IM, sublingual, and oral routes all
require absorption time and may involve first-pass hepatic metabolism, making
them less direct than IV administration. The IV route is essential for emergency
medications and when rapid therapeutic levels are needed.
2) A patient is prescribed a medication with a half-life of 6 hours. How long
will it take for 75% of a single dose to be eliminated from the body?
A) 3 hours
B) 6 hours
C) 12 hours
D) 18 hours
E) 24 hours
Correct Answer: C) 12 hours
EXPERT RATIONALE: Half-life is the time required for the plasma concentration of a
drug to decrease by 50%. After one half-life (6 hours), 50% remains. After two half-
lives (12 hours), 25% remains—meaning 75% has been eliminated. This is a
fundamental pharmacokinetic concept. Understanding half-life helps determine
dosing intervals and predict how long a medication will remain therapeutic in the
body.
3) Which of the following factors most directly affects drug bioavailability
when a medication is administered orally?
A) Patient's height and weight only
B) First-pass hepatic metabolism and absorption rate from the GI tract
C) The color of the medication tablet
,D) The time of day the medication is taken
E) The patient's age alone
Correct Answer: B) First-pass hepatic metabolism and absorption rate from
the GI tract
EXPERT RATIONALE: Bioavailability is the fraction of an administered dose that
reaches the systemic circulation. For oral medications, this is affected by absorption
from the GI tract and first-pass metabolism in the liver, where drugs are
metabolized before reaching the general circulation. Some medications have low
oral bioavailability due to extensive first-pass metabolism, requiring alternative
routes (sublingual, IV) for better therapeutic effect. Height, weight, tablet color, and
time of day are not primary determinants of bioavailability.
4) A nurse notes that a patient has been on the same dose of a cardiac
medication for 3 months without any adverse effects, but the patient reports
diminished therapeutic response. This phenomenon is best described as
which of the following?
A) Idiosyncratic reaction
B) Tolerance
C) Hypersensitivity
D) Anaphylaxis
E) Drug accumulation
Correct Answer: B) Tolerance
EXPERT RATIONALE: Tolerance is a decreased response to a drug with continued
use, requiring higher doses to achieve the same therapeutic effect. The patient is
experiencing diminished therapeutic response to the same dose after prolonged
use. This can occur due to receptor downregulation, enzyme induction, or
physiological adaptation. Idiosyncratic reactions are unpredictable responses;
hypersensitivity and anaphylaxis are allergic phenomena; and drug accumulation
typically causes increased effects, not decreased response.
, 5) Which of the following best explains why a patient with severe liver disease
requires a lower dose of a medication metabolized hepatically?
A) The liver is unable to absorb medications
B) Hepatic impairment decreases the rate of drug metabolism, prolonging drug
effect and increasing the risk of toxicity
C) The liver prevents medication absorption in the GI tract
D) Severe liver disease increases medication excretion
E) The liver activates all pro-drugs
Correct Answer: B) Hepatic impairment decreases the rate of drug
metabolism, prolonging drug effect and increasing the risk of toxicity
EXPERT RATIONALE: The liver is the primary site of drug metabolism for most
medications. In liver disease, the hepatic enzymes responsible for metabolizing
drugs are impaired, leading to slower drug clearance. This causes drugs to
accumulate in the body, prolonging their effects and increasing the risk of toxicity.
Lower doses allow therapeutic levels to be maintained without accumulation. The
liver doesn't prevent absorption; rather, it metabolizes absorbed drugs. Liver
disease decreases (not increases) excretion of metabolized products.
6) A patient is prescribed a medication with narrow therapeutic index. Which
nursing action is most important?
A) Administer the medication without monitoring levels
B) Monitor serum drug levels, assess for toxicity signs, and ensure precise dosing
and timing
C) Increase the dose to ensure therapeutic effect
D) Give the medication only when the patient requests it
E) Discontinue the medication if any side effect occurs